Atlas Trials

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Clinical trial NCT02016872 · COMPLETED

Trial details

NCT number
NCT02016872
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small-Cell-Lung Cancer (NSCLC)
Start date
2013-12-16
Primary completion
2024-07-08
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.